AssayIndex

QSC-2502-D6210

Retatrutide · 5 mg declared · Qingdao Sigma Chemical Co., Ltd. · manufactured 02 Feb 2025

CHARACTERISED
Lot code
QSC-2502-D6210
Supplier
QSC — Qingdao Sigma Chemical Co., Ltd.
Compound
Retatrutide
Compound class
Incretin analogues and co-agonists
Declared label claim
5mg
Manufacture date
02 Feb 2025
Index quarter
2025-Q3
Independent assays
3
Laboratories involved
PeptideMeter, Janoshik
Provenance mix
Buyer-sourced ×3
Section 1

Reproducibility across independent tests

Every report below is an observation of the same physical material. What they disagree about is measurement; what they agree about is the lot. The size of the disagreement is compared against what the contributing laboratories' own repeatability figures predict.

Independent assays 3
Median purity 98.24% n=3
Spread (max − min) 0.74pp n=3
Standard deviation 0.373pp n=3
95.596.397.197.998.799.5100.3This lot (QSC-2502-D6210)This lot (QSC-2502-D6210): Q1 98.02, median 98.24, Q3 98.38, n=3n=3All RetatrutideAll Retatrutide: Q1 97.92, median 98.44, Q3 98.82, n=510outlier 95.85outlier 95.94outlier 96.15outlier 96.38n=510 Purity (% area)
Figure 1. This lot's independent purity results against the whole Retatrutide record set in the index. The vertical line is the index acceptance specification for the incretin analogues and co-agonists class, 96.5 % area. A narrow box on the top row against a wide box on the bottom row is the ideal reading: it means the disagreement between lots is much larger than the disagreement within this one.
Section 2

Member reports 3

Every report the index holds on this lot. Each is a page carrying its own chromatogram, mass spectrum, mass balance, provenance and caveats.

ReportLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-018669QSC-2502-D6210PeptideMeter2025-Q397.797.26Buyer-sourced0PASS
AX-2025-018670QSC-2502-D6210Janoshik2025-Q398.246.41Buyer-sourced0PASS
AX-2025-018671QSC-2502-D6210Janoshik2025-Q398.536.9694.1Buyer-sourced0PASS
Section 3

By laboratory

Where more than one laboratory assayed this lot, the difference between them is a paired observation of their relative bias — the same material, the same time window, different instruments. Those pairs are what the index's bias estimates are built from.

LaboratoryReportsPurity results (% area)MedianGradientPublished bias (pp)Bias-adjusted
PeptideMeter197.7997.7928min-0.0597.84
Janoshik298.24, 98.5398.3830min+0.0098.38

This lot contributes 1 paired comparison to the inter-lab analysis.

Section 4

The supplier's certificate for this lot

One number the supplier wrote, beside the median of the numbers other people measured on the same physical material. That comparison is only available because the index groups by lot.

FigureSupplier COAThis reportIndex note
Purity (% area)98.3097.79divergence +0.06 pp vs batch median
Total impurities (% area)1.702.21
Largest single impurity (% area)not stated1.24
Water (%)4.87.26
Counter-ion (%)not stated7.03
Peptide content (%w/w)90.4not determined
Endotoxin (EU/mg)not statednot determined
Method stated on certificateYEScolumn, gradient and wavelength given
Section 5

Impurity fingerprint

The named impurities reported across this lot's assays, with how consistently each was seen. A fingerprint is what allows two lot numbers held by different companies to be identified as one bulk.

Named impurityReported inMedian % areaRange
C18 diacid regioisomer3 / 30.830.09–1.24
oxidised Trp (+16 Da)3 / 30.380.07–0.57
des-Aib20 analogue3 / 30.180.12–0.41
truncated (5-39)3 / 30.130.08–0.84
incomplete Fmoc removal (+222 Da)3 / 30.050.03–0.05
[D-Aib2]-diastereomer3 / 30.040.03–0.30
Section 7

What this rollup does not establish